Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Intelligent Material Solutions Inc. maintains a concentrated patent portfolio within the Biotechnology & Pharmaceuticals technology area. The data indicates 2 pending office actions, both of which are assigned to 1 distinct examiner. This 2:1 ratio of pending actions to examiners suggests a focused prosecution environment where a single individual oversees the company's entire active workload at the USPTO.
The busiest examiner, KIRWIN, STEFANIE JOHANNA, is responsible for 2 busiest examiner pending actions. Because all current work is situated within 1 distinct art unit, the company benefits from a unified regulatory framework. For a practitioner, this concentration simplifies the logistical aspects of prosecution, as there is no need to reconcile different examiner styles or art unit policies across the portfolio.
In the Biotechnology & Pharmaceuticals sector, technical requirements are often complex, but the presence of only 1 distinct examiner allows for a consistent dialogue. The 2 pending office actions under KIRWIN, STEFANIE JOHANNA mean that any arguments or precedents established in one case are likely to be highly relevant to the other. This structure enables a streamlined strategy focused on the specific interpretive tendencies of a single point of review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIRWIN, STEFANIE JOHANNA | 2 | 15.9% | +31.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17269108 | MULTIPLEX DEVICE UTILIZING LINEAR ARRAY WITH SLANTED TEST LINES ON A LATERAL FLOW STRIP OR MICROFLUIDIC DEVICE | KIRWIN, STEFANIE JOHANNA | 63d |
| 17221140 | MULTI-ASSAY RAPID DIAGNOSTIC PANEL | KIRWIN, STEFANIE JOHANNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17269108 | MULTIPLEX DEVICE UTILIZING LINEAR ARRAY WITH SLANTED TEST LINES ON A LATERAL FLOW STRIP OR MICROFLUIDIC DEVICE | KIRWIN, STEFANIE JOHANNA | 63d |
| 17221140 | MULTI-ASSAY RAPID DIAGNOSTIC PANEL | KIRWIN, STEFANIE JOHANNA | — |
| Art Unit | Apps |
|---|---|
| 1677 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17221140 | MULTI-ASSAY RAPID DIAGNOSTIC PANEL | KIRWIN, STEFANIE JOHANNA | 1677 | §103 | Final Rejection | — | Pending | Apr 02, 2021 |
| 17269108 | MULTIPLEX DEVICE UTILIZING LINEAR ARRAY WITH SLANTED TEST LINES ON A LATERAL FLOW STRIP OR MICROFLUIDIC DEVICE | KIRWIN, STEFANIE JOHANNA | 1677 | §103§112 | Non-Final OA | 63d | Pending | Feb 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial